YOLFTbeta
90

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B

900904 · SHG · Healthcare / Drug Manufacturers - General

0.404USD-0.01 (-2.65%)

Price History

Full chart

Market Stats

Previous Close0.415
Open0.405
Day Range0.401 – 0.405
52-Week Range0.403 – 0.538
Volume30.40K
Market Cap234.99M
P/E (TTM)44.00
Forward P/E0.00
EPS0.01
Dividend Yield2.33%
Beta0.56
50-Day Avg0.4542
200-Day Avg0.4731

About

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sales of pharmaceuticals in China and internationally. The company offers patented anti-tumor drugs; topical antibacterial series; products for hypertension, hyperlipidemia, and hyperglycemia chronic diseases; classic Chinese medicine cough relief series; classic tonic product series; Miao medicine for strengthening muscles and bones series; and magical doll medicine series. It also provides toothache relief drops; parsnicillin tablets, compound amino acid vitamin capsules, compound chlorhexidine dexamethasone, nasal and mouth cleansing spray, constipation relief capsules, anwei tablets, motherwort paste, gynecological menstrual regulating tablets, Sangju cold tablets, hawthorn granules, isatis root granules, col and cough syrup, and gastritis relief granules, as well as acetaminophen, caffeine, and flavoxate tablets. The companys products are used for therapeutic areas such as anti-tumor, cold and cough relief, cardiovascular and cerebrovascular diseases, rheumatic bone pain, antifungal, tonifying and calming mind, and gynecological diseases. In addition, it is involved in wholesale and retail trade, and culture and art businesses; provision of software and information technology services. It also exports its products. The company was founded in 1992 and is based in Shanghai, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - General
  • CEOMr. Feng Bin
  • Employees1.20K
  • HeadquartersChangfa Building, Shanghai, China, 200003, China
  • Websitehttps://www.gzsq.com

Leadership

  • Mr. Feng BinGM & Director · b. 1972
  • Mr. Zhimian ChenCFO & Director · b. 1971
  • Mr. Kejing WuBoard Secretary · b. 1977
  • Mr. Xiajuan WangAccounting Supervisor

Financials

Income Statement

Currency: CNY2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.59B1.60B1.74B1.85B1.93B1.82B2.30B2.39B2.34B2.05B1.95B
Growth (%)-+0.31%+8.63%+6.75%+4.03%-5.63%+26.61%+3.72%-2.00%-12.48%-4.71%
Cost of Revenue414.49M541.18M689.98M723.71M709.91M735.25M916.70M1.12B1.17B1.08B1.07B
Gross Profit1.18B1.06B1.05B1.13B1.22B1.08B1.39B1.26B1.17B973.74M880.69M
Gross Margin73.98%66.13%60.25%60.94%63.17%59.58%60.20%52.90%49.93%47.53%45.11%
Operating Expense923.27M852.43M875.31M986.62M1.03B1.07B1.30B1.16B1.05B839.36M769.92M
Operating Income255.16M204.26M170.43M142.58M191.01M11.32M83.72M99.62M116.51M134.38M110.77M
Operating Margin16.02%12.78%9.82%7.69%9.91%0.62%3.64%4.17%4.98%6.56%5.67%
EBITDA--204.88M183.13M172.59M-282.47M174.04M177.03M191.46M191.87M167.92M
EBITDA Margin--11.80%9.88%8.95%-15.53%7.56%7.41%8.18%9.36%8.60%
Net Income216.73M182.06M129.60M106.09M83.97M-341.20M69.62M48.55M57.00M71.39M38.24M
Net Income Margin13.61%11.39%7.47%5.73%4.36%-18.76%3.02%2.03%2.43%3.48%1.96%
R&D23.87M14.67M23.87M22.85M19.96M42.79M50.95M45.99M32.30M32.89M30.24M
R&D as % of Total Revenue1.50%0.92%1.38%1.23%1.04%2.35%2.21%1.93%1.38%1.61%1.55%
Interest Expense00010.54M9.13M4.94M8.34M17.37M14.76M12.80M10.07M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.57%0.47%0.27%0.36%0.73%0.63%0.62%0.52%

Balance Sheet

Currency: CNY2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.67B3.00B3.10B3.13B3.56B3.10B3.15B3.39B3.28B3.12B3.15B
Total Liabilities384.98M567.56M565.34M527.74M894.60M770.28M756.45M1.01B888.77M689.01M747.59M
Total Equity2.23B2.36B2.46B2.54B2.62B2.28B2.34B2.33B2.34B2.36B2.32B
Cash263.53M309.20M284.29M205.81M596.05M481.49M493.80M656.49M715.28M779.39M594.09M

Cash Flow

Currency: CNY2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow30.12M570.41K66.99M148.53M128.28M99.10M184.26M319.23M215.59M207.79M124.47M
Investing Cash Flow-44.14M-38.15M-111.99M-119.11M-74.38M-94.08M-85.58M----
Financing Cash Flow-19.08M83.24M20.10M-107.89M336.34M-119.72M-86.30M----
Capital Expenditure66.18M42.87M108.84M110.25M76.96M96.31M85.96M26.64M24.51M36.39M33.22M
Free Cash Flow---41.85M38.28M51.32M2.79M98.30M292.59M191.08M171.39M91.26M
Dividends Paid31.32M37.20M29.60M22.04M4.41M5.83M3.97M68.97M66.29M64.18M88.22M
FCF to OCF---62.48%25.77%40.00%2.82%53.35%91.65%88.63%82.49%73.32%
Dividend Paid to FCF---70.73%57.57%8.60%208.80%4.04%23.57%34.69%37.45%96.68%

Earnings

Report DateMar 31, 2007Jun 30, 2007Sep 30, 2007Dec 31, 2007Mar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023
EPS Estimate-----------------------------------------------------------------
EPS Actual0.000.01-0.000.000.000.000.01-0.01-0.000.010.00-0.030.000.010.00-0.010.010.010.000.000.000.01-0.000.000.000.020.010.020.010.020.010.010.010.010.020.020.010.010.010.020.010.010.010.010.010.010.000.010.010.010.010.000.000.01-0.05-0.050.010.010.000.000.010.000.01-0.000.01
Surprise-----------------------------------------------------------------
Timing-----------------------------------------------------------------

Key Statistics & Ratios

Market Cap234.99M
Enterprise Value546.66M
Trailing P/E44.00
Forward P/E0.00
Price / Sales0.13
Price / Book0.69
EPS0.01
Book Value0.6412
Revenue (TTM)1.84B
Gross Profit (TTM)782.69M
EBITDA145.87M
Profit Margin1.49%
Operating Margin5.04%
Return on Equity1.30%
Return on Assets1.39%
Shares Outstanding54.75M
Shares Float312.20M
Beta0.56
Dividend Yield2.33%
Dividend Rate0.01
Payout Ratio139.07%

Dividends

20231×
0.01Jun 27, 2023
20221×
0.01Jul 19, 2022
20181×
0.00Jul 27, 2018
20171×
0.00Jul 27, 2017
20161×
0.01Jul 8, 2016
20151×
0.01Jul 6, 2015

Stock Splits

  • Jul 6, 20156:5
  • Jul 21, 199823:20
  • Jul 14, 199723:20
  • Jul 8, 199623:20